Spero Therapeutics, Inc. Quarterly Marketable Securities, Current in USD from Q1 2018 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Spero Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q1 2018 to Q4 2022.
  • Spero Therapeutics, Inc. Marketable Securities, Current for the quarter ending December 31, 2022 was $0.000, a 100% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $0 -$33.8M -100% Dec 31, 2022 10-K 2023-03-30
Q3 2022 $0 -$10.6M -100% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $0 -$27.7M -100% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $49.9M +$11.2M +29% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $33.8M -$7.88M -18.9% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $10.6M +$8.56M +427% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $27.7M +$21.6M +360% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $38.6M +$14.2M +57.8% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $41.7M -$10.6M -20.3% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $2M -$46.3M -95.9% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $6.02M -$26.3M -81.4% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $24.5M -$32.5M -57.1% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $52.3M -$29M -35.7% Dec 31, 2019 10-K 2021-03-11
Q3 2019 $48.3M -$42.5M -46.8% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 $32.3M +$14.4M +80.1% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $57M +$34.2M +150% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $81.4M Dec 31, 2018 10-K 2020-03-16
Q3 2018 $90.7M Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $17.9M Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $22.8M Mar 31, 2018 10-Q 2018-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.